Vancomycin in ICU Patients with Gram-Positive Infections: Initial Trough Levels and Mortality

BACKGROUND: Vancomycin is one of the most common therapeutic agents for treating gram-positive infections, particularly in critically ill patients. The aim of this study was to identify factors associated with initial therapeutic vancomycin trough levels and mortality in a tertiary-care intensive ca...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Ther Clin Risk Manag
Hlavní autoři: Alshehri, Nadiyah, Ahmed, Anwar E, Yenugadhati, Nagarajkumar, Javad, Sundas, Al Sulaiman, Khalid, M Al-Dorzi, Hasan, Aljerasiy, Majed, Badri, Motasim
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7569025/
https://ncbi.nlm.nih.gov/pubmed/33116547
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S266295
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky